Chen Yi-Fen, Lin Wei-Che, Yu Su Ting-, Hsieh Tzu-Yun, Hung Kai-Yin, Hsu Mei-Hsin, Lin Ying-Jui, Kuo Hsuan-Chang, Hung Pi-Lien
Department of Pediatrics, Division of Pediatric Neurology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rare Childhood Neurologic Disease Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Department of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Nutrition. 2025 Jun;134:112730. doi: 10.1016/j.nut.2025.112730. Epub 2025 Feb 25.
The ketogenic diet (KD) is an effective alternative therapy for drug-resistant epilepsy (DRE). However, there are no established predictors for KD effectiveness. We aimed to investigate the impact of 12 months of KD therapy (KDT) on brain connectivity, as measured by functional magnetic resonance imaging (fMRI), and its correlation with seizure control, behavioral/mood alterations, and parental stress.
Children with DRE were enrolled in this single-center, prospective cohort study from February 2020 to October 2021. They were divided into a control group and a KDT group. The Child Behavior Checklist (CBCL) and Parental Stress Index (PSI) were administered to parents at the initiation of KDT (T0) and at 12 months (T1). Resting-state fMRI was performed at T0 and at 6 months of KDT. The primary outcome was the between-group difference in the change of CBCL/PSI scores, and brain connectivity metrics after KDT, and the secondary outcome involved measuring their correlation with seizure reduction rates.
Twenty-two patients with DRE were enrolled. We had 13 patients in the control group and 9 in the KDT group. Our data revealed that 12 months of KDT can reduce monthly seizure frequency. Several subscales of CBCL T-scores were higher at T0 compared with the control group, then becoming comparable at T1. The PSI scores from 'mothers' reports reduced after receiving KDT. The changes in node assortativity (ΔAssortativity) were positively correlated with behavioral problems and negatively with seizure reduction rates in the KD group.
Twelve months of KDT can reduce monthly seizure frequency and improve mood/behavioral disturbances in patients with DRE. Furthermore, KDT could relieve primary caregivers' stress. A lower ΔAssortativity value was associated with better behavioral outcomes and greater seizure reduction. The ΔAssortativity value in fMRI may be a crucial predictor for the effectiveness of KDT.
生酮饮食(KD)是治疗药物难治性癫痫(DRE)的一种有效替代疗法。然而,目前尚无确定的KD疗效预测指标。我们旨在研究12个月的生酮饮食疗法(KDT)对脑连接性的影响(通过功能磁共振成像(fMRI)测量),及其与癫痫控制、行为/情绪改变和家长压力的相关性。
2020年2月至2021年10月,DRE患儿被纳入这项单中心前瞻性队列研究。他们被分为对照组和KDT组。在KDT开始时(T0)和12个月时(T1),向家长发放儿童行为检查表(CBCL)和家长压力指数(PSI)。在T0和KDT治疗6个月时进行静息态fMRI检查。主要结局是KDT后CBCL/PSI评分变化以及脑连接性指标的组间差异,次要结局包括测量它们与癫痫发作减少率的相关性。
共纳入22例DRE患者。其中对照组13例,KDT组9例。我们的数据显示,12个月的KDT可降低每月癫痫发作频率。与对照组相比,CBCL T评分的几个子量表在T0时较高,在T1时变得相当。接受KDT后,母亲报告的PSI评分降低。KD组中节点聚集系数的变化(Δ聚集系数)与行为问题呈正相关,与癫痫发作减少率呈负相关。
12个月的KDT可降低DRE患者的每月癫痫发作频率,并改善情绪/行为障碍。此外,KDT可减轻主要照顾者的压力。较低的Δ聚集系数值与更好的行为结局和更大程度的癫痫发作减少相关。fMRI中的Δ聚集系数值可能是KDT疗效的关键预测指标。